£2.9M
The funding round will support the clinical development of the company's transdermal testosterone patch for post-menopausal women.
M
Medherant
Medherant develops novel transdermal drug delivery patches for therapeutic applications.
United Kingdom—Founded 2015
£2.9MTotal raised
Medherant is a clinical-stage pharmaceutical company developing transdermal drug delivery patches.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from Medherant's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
DH
David Haddleton
Professor of Polymer Chemistry